Men with prostate cancer who are physically active enjoy a lower death rate, according to a new study published online in Cancer Epidemiology, Biomarkers & Prevention.
Higher levels of physical activity were linked with reduced rates of overall and prostate cancer–specific mortality.
According to the Swedish researchers, lower mortality rates were experienced by men performing 5 or more hours of activity each day, including walking or bicycling for 20 minutes or more each day, performing household work daily for an hour plus, and exercising for an hour plus each week. For prostate cancer-specific mortality, significantly lower mortality rates were seen among men walking, bicycling, and exercising at the levels mentioned above.
For the study, investigators examined data from 4,623 men diagnosed with localized prostate cancer from 1997–2002. After a follow-up of 10 or more years, 194 men died from prostate cancer and 561 from any cause.
The study strengthens previous research on the benefits of exercise for cancer in general, and prostate cancer, more specifically.
Recommending exercise to prostate cancer patients and encouraging them to stay active is relatively easy and may lead to better health outcomes.
Yet another study is confirming the benefits of physical activity following the diagnosis of cancer, this time of prostate cancer, on all-cause and prostate-specific survival, Swedish researchers report.
The study was published online December 19 in Cancer Epidemiology, Biomarkers & Prevention.
“Being physically active has many positive effects on health, and now we can see that it has specific effects on survival among prostate cancer patients as well,” Stephanie Bonn, MSc, Karolinska Institute, Stockholm, Sweden, told Medscape Medical News.
Enjoying our content?
Thanks for visiting Renal & Urology News. We hope you’re enjoying the latest clinical news, full-length features, case studies, and more.
You’ve viewed {{metering-count}} of {{metering-total}} articles this month. If you wish to read unlimited content, please log in or register below. Registration is free.
{{login-button}} {{register-button}}
Log in to continue reading this article.
Don’t miss out on today’s top content on Renal & Urology News. Register for free and gain unlimited access to:
- Clinical News, with personalized daily picks for you
- Case Studies
- Conference Coverage
- Full-Length Features
- Drug Monographs
- And More
{{login-button}} {{register-button}}
Want to read more?
Please login or register first to view this content.